Esperion Therapeutics reported $71.22M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amarin AMRN:US 157.27M 34.34M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Cytokinetics CYTK:US $ 99.84M 18.14M
Daiichi Sankyo 4568:JP 245.94B 38.74B
Eli Lilly And LLY:US $ 5277.9M 127.8M
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Geron GERN:US $ 28.05M 749K
Halozyme Therapeutics HALO:US $ 118.3M 76.7M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Intra Cellular Therapies ITCI:US $ 143.5M 35.84M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Merk MRK:US $ 9666M 666M
Minerva Neurosciences NERV:US $ 6.97M 1.02M
Moderna Inc MRNA:US 2.3B 463M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Pfizer PFE:US $ 15640M 148M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Seattle Genetics SGEN:US $ 630.61M 71.1M
United Therapeutics UTHR:US $ 265.1M 89.5M
Vanda Pharmaceuticals VNDA:US $ 60.93M 6.93M